Several studies have reported the hyperactivation of the oncogenic kinase AKT1 in 40-60% of sporadic breast cancers and in 40% of sporadic ovarian cancers (Sun et al., 2001; Yang et al., 2006; Plo et al., 2008). Here, AKT1 is linked to breast carcinoma.